Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.8K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDA-MutPred: Reliable prediction of binding affinity change upon mutation in protein-DNA complexes.

International journal of biological macromolecules·2026
Same author

Biomaterial-associated molecular patterns (BAMPs) modulate macrophage polarization in bone grafting.

PloS one·2026
Same author

Classification of driver and passenger mutations in different cancer types using deep neural networks.

Bioinformatics advances·2026
Same author

Investigating protein aggregation in protein-carbohydrate interfaces using sequence and structural features.

Biochimica et biophysica acta. Proteins and proteomics·2026
Same author

Molecular signatures of resilience to Alzheimer's disease in neocortical layer 4 neurons.

Nature communications·2026
Same author

Integrating Sequence, Structure, and Graph-based Features for Elucidating the Stability of Thermophilic Proteins.

Journal of molecular biology·2025

Related Experiment Video

Updated: Nov 10, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.1K

Exploring Common Therapeutic Targets for Neurodegenerative Disorders Using Transcriptome Study.

S Akila Parvathy Dharshini1, Sherlyn Jemimah1, Y H Taguchi2

  • 1Protein Bioinformatics Lab, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India.

Frontiers in Genetics
|April 5, 2021
PubMed
Summary
This summary is machine-generated.

Researchers identified common genetic variants and gene expression changes in Brodmann area 9 (BA9) for Alzheimer's disease (AD) and Parkinson's disease (PD). They propose MAPK1, VEGFR1/FLT1, and FGFR1 as potential drug targets to reduce neuroinflammation and protect neurons.

Keywords:
Brodmann area-9blood-brain barrierenergy dysfunctioninflammatory responsetranscription factor

More Related Videos

Purification of Transcripts and Metabolites from Drosophila Heads
12:49

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

22.1K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.7K

Related Experiment Videos

Last Updated: Nov 10, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.1K
Purification of Transcripts and Metabolites from Drosophila Heads
12:49

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

22.1K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.7K

Area of Science:

  • Neuroscience
  • Genomics
  • Pharmacology

Background:

  • Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative disorders with shared pathological pathways, but current treatments only manage symptoms.
  • Neuronal energy dysfunction contributes to pathogenesis and eventual cell death in these conditions.
  • The Brodmann area 9 (BA9) is implicated in both AD and PD, affecting cognitive, motor, and memory functions.

Purpose of the Study:

  • To identify common therapeutic targets for AD and PD by analyzing transcriptome data from the BA9 region.
  • To investigate shared pathological pathways and genetic variations in BA9 relevant to both neurodegenerative diseases.

Main Methods:

  • RNA-sequencing (RNA-seq) was used to analyze BA9 transcriptome data from disease and control samples.
  • Fastq files were mapped to the hg38 human genome assembly to identify common variants and differentially expressed genes (DEGs).
  • Functional interaction networks were constructed to analyze relationships between transcription factors (TFs) and DEGs.

Main Results:

  • Common genetic variants were identified, primarily in the 3' UTR region, impacting TF binding motifs involved in epigenetic regulation (methylation and acetylation).
  • Differentially expressed genes (DEGs) were identified in BA9, suggesting shared molecular pathways in AD and PD.
  • Functional networks revealed interactions between TFs and DEGs, highlighting key regulatory mechanisms.

Conclusions:

  • MAPK1, VEGFR1/FLT1, and FGFR1 are proposed as promising therapeutic targets based on expression signature analysis.
  • Targeting these genes may restore blood-brain barrier function, reduce neuroinflammation, and protect neurons in AD and PD.
  • This study provides insights into common pathogenic mechanisms and potential drug targets for neurodegenerative diseases.